| Identification | More | [Name]
N-tert-Butoxycarbonyl-4-cyanophenyl-D-alanine | [CAS]
146727-62-0 | [Synonyms]
BOC-4-CYANO-D-PHENYLALANINE
BOC-4-CYANO-D-PHE-OH
BOC-D-4-CYANOPHE
BOC-D-4-CYANOPHENYLALANINE
BOC-D-PHE(4-CN)-OH
BOC-D-PHE(P-CN)-OH
BOC-P-CYANO-D-PHENYLALANINE
BOC-P-CYANO-D-PHE-OH
N-ALPHA-T-BUTOXYCARBONYL-(4-CYANO)-D-PHENYLALANINE
N-TERT-BUTOXYCARBONYL-4-CYANOPHENYL-D-ALANINE
RARECHEM BK PT 0161
(R)-N-BOC-4-CYANOPHENYLALANINE
BOC-D-4-CYANOPHENYLALANINE 98%
Boc-D-4-CN-Phe-OH
(R)-N-BOC-4-CYANOPHENYLALANINE 98%
N-alpha-t-Butyloxycarbonyl-4-cyano-D-phenylalanine
(R)-N-BOC-4-CYANOPHENYLALANINE, 95%, 98% EE
(R)-N-BOC-4-Cyanophenylalanine, 98% ee
Boc-D-4-Cyano-phe-OH | [Molecular Formula]
C15H18N2O4 | [MDL Number]
MFCD00672527 | [Molecular Weight]
290.31 | [MOL File]
146727-62-0.mol |
| Chemical Properties | Back Directory | [Appearance]
off-white powder | [Melting point ]
152.6 °C | [Boiling point ]
432.4°C (rough estimate) | [density ]
1.1611 (rough estimate) | [refractive index ]
1.6280 (estimate) | [storage temp. ]
-15°C | [solubility ]
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | [form ]
Powder | [pka]
3.73±0.10(Predicted) | [Optical Rotation]
Consistent with structure | [BRN ]
9339089 | [Major Application]
peptide synthesis | [InChI]
1S/C15H18N2O4/c1-15(2,3)21-14(20)17-12(13(18)19)8-10-4-6-11(9-16)7-5-10/h4-7,12H,8H2,1-3H3,(H,17,20)(H,18,19)/t12-/m1/s1 | [InChIKey]
RMBLTLXJGNILPG-GFCCVEGCSA-N | [SMILES]
CC(C)(C)OC(=O)N[C@H](Cc1ccc(cc1)C#N)C(O)=O | [CAS DataBase Reference]
146727-62-0(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xn | [Risk Statements ]
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed . | [Safety Statements ]
S36/37:Wear suitable protective clothing and gloves . | [WGK Germany ]
3
| [HazardClass ]
6.1 | [HazardClass ]
IRRITANT | [HS Code ]
29223900 | [Storage Class]
11 - Combustible Solids |
| Hazard Information | Back Directory | [Chemical Properties]
off-white powder | [Uses]
N-Boc-4-cyano-D-phenylalanine is used as pharmaceutical intermediate. | [reaction suitability]
reaction type: Boc solid-phase peptide synthesis |
|
|